🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Trametinib Tx Shows Promise in Tough-to-Treat LGSOC medpagetoday.com/meetingcoverag…

Trametinib Boosts PFS and Response Rates in Low-Grade Ovarian Cancer onclive.com/conference-cov… via @onclive

You go to a hospital and don’t wear a mask!? What a jerk! You need to re-evaluate your values and concern for others!

#Powerfulvoices from #lowgradeserous #ovariancancer woman around the world, for World Ovarian Cancer Day. #WOCD2020 Donate to research to help women live longer at cureourovariancancer.org

KRAS May Predict Benefit of MEK Inhibitors in Some Ovarian Cancers medpagetoday.com/meetingcoverag…

One Strikeout, One Hit Against Low-Grade Serous Carcinomas medscape.com/viewarticle/93… via @medscape

doi.org/10.1016/j.ygyn…

OncLive Honors 13 Cancer Care Pioneers onclive.com/view/onclive-h… via @onclive

Rare Ovarian Cancer Awareness Read more: bit.ly/3H1QgiN #OvarianCancer

This is a new twitter site in which I will be disseminating scientific advances and news about rare ovarian cancers. Check it out. DMG

Article reports Norwegian experience with ovarian germ cell tumors. Message: They should be treated at major centers. ncbi.nlm.nih.gov/pubmed/24001518

Serous borderline ovarian tumors with BRAF mutations less likely to recur as low-grade serous cancer #ovariancancer ncbi.nlm.nih.gov/pubmed/24105490

"What We Know and What We Need to Know About Neoadjuvant Chemotherapy in Advanced Ovarian Cancer" ascopost.com/issues/october… via @ascopost

Largest study to date demonstrates the activity of bevacizumab in low-grade serous carcinoma ncbi.nlm.nih.gov/pubmed/28139261

Hormone Therapy Prolongs PFS in Low-grade Serous Cancer medscape.com/viewarticle/87… via @medscape

The Crisis in Gynecological Cancer Research nyti.ms/2y0U13y